New imaging techniques for liver diseases

Journal of Hepatology

Volumn 62, Issue 3, 2015, Pages 690-700

  Van Beers, Bernard E ^a   Daire, Jean Luc ^a   Garteiser, Philippe ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Dynamic gadoxetate enhanced MR imaging; Elastography; Imaging biomarkers; Liver diseases; Liver tumors; Magnetic resonance imaging; Perfusion and diffusion imaging; Ultrasonography

Indexed keywords

ARTICLE; DIFFUSION WEIGHTED IMAGING; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC CONTRAST ENHANCED ULTRASONOGRAPHY; DYNAMIC ULTRASOUND ELASTOGRAPHY; ECHOGRAPHY; ELASTOGRAPHY; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER TUMOR; MAGNETIC RESONANCE ELASTOGRAPHY; META ANALYSIS (TOPIC); NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PRIORITY JOURNAL; ULTRASOUND ELASTOGRAPHY; DIAGNOSTIC IMAGING; LIVER DISEASES; LIVER NEOPLASMS; PROCEDURES; TRENDS;

CONTRAST MEDIUM;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; DIFFUSION MAGNETIC RESONANCE IMAGING; ELASTICITY IMAGING TECHNIQUES; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING;

EID: 84923031248     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.10.014     Document Type: Review

References (131)

1. N. Galea, V. Cantisani, and B. Taouli Liver lesion detection and characterization: role of diffusion-weighted imaging J Magn Reson Imaging 37 2013 1260 1276
2. R.N. Low Abdominal MRI advances in the detection of liver tumours and characterisation Lancet Oncol 8 2007 525 535
3. B.E. Van Beers, S. Doblas, and R. Sinkus New acquisition techniques: fields of application Abdom Imaging 37 2011 155 163
4. B.E. Van Beers, C.M. Pastor, and H.K. Hussain Primovist, Eovist: what to expect? J Hepatol 57 2012 421 429
5. F. Kiessling, S. Fokong, J. Bzyl, W. Lederle, M. Palmowski, and T. Lammers Recent advances in molecular, multimodal and theranostic ultrasound imaging Adv Drug Deliv Rev 72 2014 15 27
6. M. Claudon, C.F. Dietrich, B.I. Choi, D.O. Cosgrove, M. Kudo, and C.P. Nolsoe Guidelines and good clinical practice recommendations for contrast enhanced utrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS Ultrasound Med Biol 39 2013 187 210
7. L. Bolondi The appropriate allocation of CEUS in the diagnostic algorithm of liver lesions: a debated issue Ultrasound Med Biol 39 2013 183 185
8. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
9. M. Kudo, N. Izumi, N. Kokudo, O. Matsui, M. Sakamoto, and O. Nakashima Management of hepatocellular carcinoma in Japan: Consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version Dig Dis 29 2011 339 364
10. J. Bruix, and M. Sherman Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
11. EASL, and EORTC EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
12. R. Vilana, A. Forner, L. Bianchi, A. Garcia-Criado, J. Rimola, and C.R. de Lope Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound Hepatology 51 2010 2020 2029
13. H. Trillaud, J.M. Bruel, P.J. Valette, V. Vilgrain, G. Schmutz, and R. Oyen Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter study in comparison to CT and MRI World J Gastroenterol 15 2009 3748 3756
14. M. Westwood, M. Joore, J. Grutters, K. Redekop, N. Armstrong, and K. Lee Contrast-enhanced ultrasound using SonoVue(R) (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis Health Technol Assess 17 2013 1 243
15. N. Lassau, S. Koscielny, L. Chami, M. Chebil, B. Benatsou, and A. Roche Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification-preliminary results Radiology 258 2011 291 300
16. M. Gauthier, F. Tabarout, I. Leguerney, M. Polrot, S. Pitre, and P. Peronneau Assessment of quantitative perfusion parameters by dynamic contrast-enhanced sonography using a deconvolution method: an in vitro and in vivo study J Ultrasound Med 31 2012 595 608
17. M. Palmowski, B. Morgenstern, P. Hauff, M. Reinhardt, J. Huppert, and M. Maurer Pharmacodynamics of streptavidin-coated cyanoacrylate microbubbles designed for molecular ultrasound imaging Invest Radiol 43 2008 162 169
18. R.J. Dewall Ultrasound elastography: principles, techniques, and clinical applications Crit Rev Biomed Eng 41 2013 1 19
19. L. Sandrin, B. Fourquet, J.M. Hasquenoph, S. Yon, C. Fournier, and F. Mal Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
20. K. Nightingale, M.S. Soo, R. Nightingale, and G. Trahey Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility Ultrasound Med Biol 28 2002 227 235
21. J. Bercoff, M. Tanter, and M. Fink Supersonic shear imaging: A new technique for soft tissue elasticity mapping IEEE Trans Ultrason Ferroelectr Freq Control 51 2004 396 409
22. S. Chen, W. Sanchez, M.R. Callstrom, B. Gorman, J.T. Lewis, and S.O. Sanderson Assessment of liver viscoelasticity by using shear waves induced by ultrasound radiation force Radiology 266 2013 964 970
23. J. Vappou Magnetic resonance- and ultrasound imaging-based elasticity imaging methods: a review Crit Rev Biomed Eng 40 2012 121 134
24. R. Sinkus, K. Siegmann, T. Xydeas, M. Tanter, C. Claussen, and M. Fink MR elastography of breast lesions: understanding the solid/liquid duality can improve the specificity of contrast-enhanced MR mammography Magn Reson Med 58 2007 1135 1144
25. N. Frulio, H. Laumonier, T. Carteret, C. Laurent, F. Maire, and C. Balabaud Evaluation of liver tumors using acoustic radiation force impulse elastography and correlation with histologic data J Ultrasound Med 32 2013 121 130
26. A. Guibal, C. Boularan, M. Bruce, M. Vallin, F. Pilleul, and T. Walter Evaluation of shearwave elastography for the characterisation of focal liver lesions on ultrasound Eur Radiol 23 2013 1138 1149
27. L. Castera Noninvasive methods to assess liver disease in patients with hepatitis B or C Gastroenterology 142 2012 1293 1302
28. M. Friedrich-Rust, M.F. Ong, S. Martens, C. Sarrazin, J. Bojunga, and S. Zeuzem Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 2008 960 974
29. F. Degos, P. Perez, B. Roche, A. Mahmoudi, J. Asselineau, and H. Voitot Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study) J Hepatol 53 2010 1013 1021
30. E.A. Tsochatzis, K.S. Gurusamy, S. Ntaoula, E. Cholongitas, B.R. Davidson, and A.K. Burroughs Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy J Hepatol 54 2011 650 659
31. L. Castera, J. Foucher, P.H. Bernard, F. Carvalho, D. Allaix, and W. Merrouche Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
32. M. Friedrich-Rust, J. Nierhoff, M. Lupsor, I. Sporea, C. Fierbinteanu-Braticevici, and D. Strobel Performance of Acoustic Radiation Force Impulse imaging for the staging of liver fibrosis: a pooled meta-analysis J Viral Hepat 19 2012 e212 219
33. G. Ferraioli, C. Tinelli, B. Dal Bello, M. Zicchetti, G. Filice, and C. Filice Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study Hepatology 56 2012 2125 2133
34. A. Berzigotti, S. Seijo, U. Arena, J.G. Abraldes, F. Vizzutti, and J.C. Garcia-Pagan Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis Gastroenterology 144 2013 102 111
35. Y. Takuma, K. Nouso, Y. Morimoto, J. Tomokuni, A. Sahara, and N. Toshikuni Measurement of spleen stiffness by acoustic radiation force impulse imaging identifies cirrhotic patients with esophageal varices Gastroenterology 144 2013 92 101
36. M. Ronot, S. Di Renzo, B. Gregoli, R. Duran, L. Castera, and B.E. Van Beers Characterization of fortuitously discovered focal liver lesions: additional information provided by shearwave elastography Eur Radiol 2014 [Epub ahead of print]
37. P. Zhang, P. Zhou, S.M. Tian, Y. Qian, J.L. Li, and R.Z. Li Diagnostic performance of contrast-enhanced sonography and acoustic radiation force impulse imaging in solid liver lesions J Ultrasound Med 33 2014 205 214
38. M. Tanter, and M. Fink Ultrafast imaging in biomedical ultrasound IEEE Trans Ultrason Ferroelectr Freq Control 61 2014 102 119
39. M. Fraquelli, C. Rigamonti, G. Casazza, M.F. Donato, G. Ronchi, and D. Conte Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C J Hepatol 54 2010 621 628
40. A. Berzigotti, and L. Castera Update on ultrasound imaging of liver fibrosis J Hepatol 59 2013 180 182
41. D. Le Bihan, E. Breton, D. Lallemand, M.L. Aubin, J. Vignaud, and M. Laval-Jeantet Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging Radiology 168 1988 497 505
42. A.R. Padhani, G. Liu, D.M. Koh, T.L. Chenevert, H.C. Thoeny, and T. Takahara Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia 11 2009 102 125
43. H.A. Dyvorne, N. Galea, T. Nevers, M.I. Fiel, D. Carpenter, and E. Wong Diffusion-weighted imaging of the liver with multiple b values: effect of diffusion gradient polarity and breathing acquisition on image quality and intravoxel incoherent motion parameters-a pilot study Radiology 266 2013 920 929
44. S.Y. Kim, S.S. Lee, J.H. Byun, S.H. Park, J.K. Kim, and B. Park Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging Radiology 255 2010 815 823
45. L. Heijmen, E.E. Ter Voert, I.D. Nagtegaal, P. Span, J. Bussink, and C.J. Punt Diffusion-weighted MR imaging in liver metastases of colorectal cancer: reproducibility and biological validation Eur Radiol 23 2012 748 756
46. A. Andreou, D.M. Koh, D.J. Collins, M. Blackledge, T. Wallace, and M.O. Leach Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases Eur Radiol 23 2013 428 434
47. S.Y. Kim, S.S. Lee, B. Park, N. Kim, J.K. Kim, and S.H. Park Reproducibility of measurement of apparent diffusion coefficients of malignant hepatic tumors: effect of DWI techniques and calculation methods J Magn Reson Imaging 36 2012 1131 1138
48. M.R. Orton, D.J. Collins, D.M. Koh, and M.O. Leach Improved intravoxel incoherent motion analysis of diffusion weighted imaging by data driven Bayesian modeling Magn Reson Med 71 2013 411 420
49. K. Coenegrachts, J. Delanote, L. Ter Beek, M. Haspeslagh, S. Bipat, and J. Stoker Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques Br J Radiol 80 2007 524 531
50. T. Parikh, S.J. Drew, V.S. Lee, S. Wong, E.M. Hecht, and J.S. Babb Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging Radiology 246 2008 812 822
51. A.D. Hardie, M. Naik, E.M. Hecht, H. Chandarana, L. Mannelli, and J.S. Babb Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI Eur Radiol 20 2010 1431 1441
52. D. Lowenthal, M. Zeile, W.Y. Lim, C. Wybranski, F. Fischbach, and G. Wieners Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging Eur Radiol 21 2011 832 840
53. M. Wagner, L. Maggiori, M. Ronot, V. Paradis, V. Vilgrain, and Y. Panis Diffusion-weighted and T2-weighted MR imaging for colorectal liver metastases detection in a rat model at 7 T: a comparative study using histological examination as reference Eur Radiol 23 2013 2156 2164
54. O.F. Donati, M.A. Fischer, N. Chuck, R. Hunziker, D. Weishaupt, and C.S. Reiner Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases Eur J Radiol 82 2013 822 828
55. M. Bruegel, K. Holzapfel, J. Gaa, K. Woertler, S. Waldt, and B. Kiefer Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique Eur Radiol 18 2008 477 485
56. F. Agnello, M. Ronot, D.C. Valla, R. Sinkus, B.E. Van Beers, and V. Vilgrain High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis Radiology 262 2012 511 519
57. P.J. Xu, F.H. Yan, J.H. Wang, Y. Shan, Y. Ji, and C.Z. Chen Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver J Comput Assist Tomogr 34 2010 506 512
58. G. Piana, L. Trinquart, N. Meskine, V. Barrau, B. Van Beers, and V. Vilgrain New MR imaging criteria with a diffusion-weighted sequence for the diagnosis of hepatocellular carcinoma in chronic liver diseases J Hepatol 55 2011 126 132
59. M.J. Park, Y.K. Kim, M.H. Lee, and J.H. Lee Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<=2.0 cm) in patients with hepatitis-induced liver cirrhosis Acta Radiol 54 2013 127 136
60. S. Doblas, M. Wagner, H.S. Leitao, J.L. Daire, R. Sinkus, and V. Vilgrain Determination of malignancy and characterization of hepatic tumor type with diffusion-weighted magnetic resonance imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived measurements Invest Radiol 48 2013 722 728
61. S. Woo, J.M. Lee, J.H. Yoon, I. Joo, J.K. Han, and B.I. Choi Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade Radiology 270 2014 758 767
62. R. Braren, J. Altomonte, M. Settles, F. Neff, I. Esposito, and O. Ebert Validation of preclinical multiparametric imaging for prediction of necrosis in hepatocellular carcinoma after embolization J Hepatol 55 2011 1034 1040
63. V. Vandecaveye, K. Michielsen, F. De Keyzer, W. Laleman, M. Komuta, and K. Op de Beeck Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome Radiology 270 2014 747 757
64. S. Bonekamp, V.G. Halappa, J.F. Geschwind, Z. Li, C.P. Corona-Villalobos, and D. Reyes Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy Radiology 268 2013 431 439
65. D. Bonekamp, S. Bonekamp, V.G. Halappa, J.F. Geschwind, J. Eng, and C.P. Corona-Villalobos Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma Eur J Radiol 83 2014 487 496
66. I.R. Kamel, D.K. Reyes, E. Liapi, D.A. Bluemke, and J.F. Geschwind Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma J Vasc Interv Radiol 18 2007 49 56
67. D.V. Sahani, T. Jiang, K. Hayano, D.G. Duda, O.A. Catalano, and M. Ancukiewicz Magnetic resonance imaging biomarkers in hepatocellular carcinoma: association with response and circulating biomarkers after sunitinib therapy J Hematol Oncol 6 2013 51
68. M. Lewin, L. Fartoux, A. Vignaud, L. Arrive, Y. Menu, and O. Rosmorduc The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study Eur Radiol 21 2011 281 290
69. Y. Cui, X.P. Zhang, Y.S. Sun, L. Tang, and L. Shen Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases Radiology 248 2008 894 900
70. M. Chiaradia, L. Baranes, J.T. Van Nhieu, A. Vignaud, A. Laurent, and T. Decaens Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis? J Magn Reson Imaging 39 2014 317 325
71. G.A. Poultsides, F. Bao, E.L. Servais, T. Hernandez-Boussard, R.P. DeMatteo, and P.J. Allen Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome Ann Surg Oncol 19 2012 2797 2804
72. M. Wagner, S. Doblas, J.L. Daire, V. Paradis, N. Haddad, and H. Leitao Diffusion-weighted MR imaging for the regional characterization of liver tumors Radiology 264 2012 464 472
73. M. Lewin, A. Poujol-Robert, P.Y. Boelle, D. Wendum, E. Lasnier, and M. Viallon Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C Hepatology 46 2007 658 665
74. A. Luciani, A. Vignaud, M. Cavet, J.T. Nhieu, A. Mallat, and L. Ruel Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study Radiology 249 2008 891 899
75. L. Annet, F. Peeters, J. Abarca-Quinones, I. Leclercq, P. Moulin, and B.E. Van Beers Assessment of diffusion-weighted MR imaging in liver fibrosis J Magn Reson Imaging 25 2007 122 128
76. H.S. Leitao, S. Doblas, G. d'Assignies, P. Garteiser, J.L. Daire, and V. Paradis Fat deposition decreases diffusion parameters at MRI: a study in phantoms and patients with liver steatosis Eur Radiol 23 2013 461 467
77. Y. Wang, D.R. Ganger, J. Levitsky, L.A. Sternick, R.J. McCarthy, and Z.E. Chen Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging AJR Am J Roentgenol 196 2011 553 561
78. A. Nassif, J. Jia, M. Keiser, S. Oswald, C. Modess, and S. Nagel Visualization of hepatic uptake transporter function in healthy subjects by using gadoxetic acid-enhanced MR imaging Radiology 264 2012 741 750
79. J. Jia, D. Puls, S. Oswald, G. Jedlitschky, J.P. Kuhn, and W. Weitschies Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid Invest Radiol 49 2014 78 86
80. X. Gu, and J.E. Manautou Regulation of hepatic ABCC transporters by xenobiotics and in disease states Drug Metab Rev 42 2010 482 538
81. A. Kitao, O. Matsui, N. Yoneda, K. Kozaka, R. Shinmura, and W. Koda The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging Eur Radiol 21 2011 2056 2066
82. M. Lagadec, S. Doblas, C. Giraudeau, M. Ronot, M. Fasseu, and V. Paradis Advanced fibrosis: correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver Radiology 10 2014 140313
83. M. Narita, E. Hatano, S. Arizono, A. Miyagawa-Hayashino, H. Isoda, and K. Kitamura Expression of OATP1B3 determines uptake of Gd-EOB-DTPA in hepatocellular carcinoma J Gastroenterol 44 2009 793 798
84. S. Walker-Samuel, M.O. Leach, and D.J. Collins Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis Phys Med Biol 51 2006 3593 3602
85. R. Materne, A.M. Smith, F. Peeters, J.P. Dehoux, A. Keyeux, and Y. Horsmans Assessment of hepatic perfusion parameters with dynamic MRI Magn Reson Med 47 2002 135 142
86. M. Hagiwara, H. Rusinek, V.S. Lee, M. Losada, M.A. Bannan, and G.A. Krinsky Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging-initial experience Radiology 246 2008 926 934
87. Y. Liu, and O. Matsui Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice Radiology 243 2007 386 395
88. International Consensus Group for Hepatocellular Neoplasia Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia Hepatology 49 2009 658 664
89. D.L. Buckley Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI Magn Reson Med 47 2002 601 606
90. N. Michoux, L. Huwart, J. Abarca-Quinones, M. Dorvillius, L. Annet, and F. Peeters Transvascular and interstitial transport in rat hepatocellular carcinomas: dynamic contrast-enhanced MRI assessment with low- and high-molecular weight agents J Magn Reson Imaging 28 2008 906 914
91. M.O. Leach, B. Morgan, P.S. Tofts, D.L. Buckley, W. Huang, and M.A. Horsfield Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging Eur Radiol 22 2012 1451 1464
92. C.S. Ng, D.L. Raunig, E.F. Jackson, E.A. Ashton, F. Kelcz, and K.B. Kim Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses AJR Am J Roentgenol 194 2010 W134 140
93. S.M. Galbraith, M.A. Lodge, N.J. Taylor, G.J. Rustin, S. Bentzen, and J.J. Stirling Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis NMR Biomed 15 2002 132 142
94. T. Heye, M.S. Davenport, J.J. Horvath, S. Feuerlein, S.R. Breault, and M.R. Bashir Reproducibility of dynamic contrast-enhanced MR imaging. Part I. Perfusion characteristics in the female pelvis by using multiple computer-aided diagnosis perfusion analysis solutions Radiology 266 2013 801 811
95. T. Heye, E.M. Merkle, C.S. Reiner, M.S. Davenport, J.J. Horvath, and S. Feuerlein Reproducibility of dynamic contrast-enhanced MR imaging. Part II. Comparison of intra- and interobserver variability with manual region of interest placement versus semiautomatic lesion segmentation and histogram analysis Radiology 266 2013 812 821
96. H. Nilsson, A. Nordell, R. Vargas, L. Douglas, E. Jonas, and L. Blomqvist Assessment of hepatic extraction fraction and input relative blood flow using dynamic hepatocyte-specific contrast-enhanced MRI J Magn Reson Imaging 29 2009 1323 1331
97. S. Sourbron, W.H. Sommer, M.F. Reiser, and C.J. Zech Combined quantification of liver perfusion and function with dynamic gadoxetic acid-enhanced MR imaging Radiology 263 2012 874 883
98. L. Annet, R. Materne, E. Danse, J. Jamart, Y. Horsmans, and B.E. Van Beers Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension Radiology 229 2003 409 414
99. N. Bastati, D. Feier, A. Wibmer, S. Traussnigg, C. Balassy, and D. Tamandl Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study Radiology 271 2014 739 747
100. H. Nilsson, L. Blomqvist, L. Douglas, A. Nordell, I. Janczewska, and E. Naslund Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis Br J Radiol 86 2013 20120653
101. D. Feier, C. Balassy, N. Bastati, J. Stift, R. Badea, and A. Ba-Ssalamah Liver fibrosis: histopathologic and biochemical influences on diagnostic efficacy of hepatobiliary contrast-enhanced MR imaging in staging Radiology 269 2013 460 468
102. A. Wibmer, A.M. Prusa, R. Nolz, T. Gruenberger, M. Schindl, and A. Ba-Ssalamah Liver failure after major liver resection: risk assessment by using preoperative gadoxetic acid-enhanced 3-T MR imaging Radiology 269 2013 777 786
103. R. Golfieri, M. Renzulli, V. Lucidi, B. Corcioni, F. Trevisani, and L. Bolondi Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to dynamic MRI in the detection of hypovascular small (
104. A. Granito, M. Galassi, F. Piscaglia, L. Romanini, V. Lucidi, and M. Renzulli Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study Aliment Pharmacol Ther 37 2013 355 363
105. L. Grazioli, M.P. Bondioni, H. Haradome, U. Motosugi, R. Tinti, and B. Frittoli Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis Radiology 262 2012 520 529
106. H. Akai, I. Matsuda, S. Kiryu, T. Tajima, H. Takao, and Y. Watanabe Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging Eur J Radiol 81 2012 2973 2977
107. M. Ronot, and V. Vilgrain Hepatocellular carcinoma: Diagnostic criteria by imaging techniques Best Pract Res Clin Gastroenterol 28 2014 795 812
108. Y.K. Kim, W.J. Lee, M.J. Park, S.H. Kim, H. Rhim, and D. Choi Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC Radiology 265 2012 104 114
109. J.P. O'Connor, A. Jackson, G.J. Parker, C. Roberts, and G.C. Jayson Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies Nat Rev Clin Oncol 9 2012 167 177
110. C.Y. Hsu, Y.C. Shen, C.W. Yu, C. Hsu, F.C. Hu, and C.H. Hsu Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil J Hepatol 55 2011 858 865
111. A.X. Zhu, D.V. Sahani, D.G. Duda, E. di Tomaso, M. Ancukiewicz, and O.A. Catalano Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: A phase II study J Clin Oncol 27 2009 3027 3035
112. S. De Bruyne, N. Van Damme, P. Smeets, L. Ferdinande, W. Ceelen, and J. Mertens Value of DCE-MRI and FDG-PET/CT in the prediction of response to preoperative chemotherapy with bevacizumab for colorectal liver metastases Br J Cancer 106 2012 1926 1933
113. R. Sinkus, M. Tanter, T. Xydeas, S. Catheline, J. Bercoff, and M. Fink Viscoelastic shear properties of in vivo breast lesions measured by MR elastography Magn Reson Imaging 23 2005 159 165
114. P. Garteiser, R.S. Sahebjavaher, L.C. Ter Beek, S. Salcudean, V. Vilgrain, and B.E. Van Beers Rapid acquisition of multifrequency, multislice and multidirectional MR elastography data with a fractionally encoded gradient echo sequence NMR Biomed 26 2013 1326 1335
115. A.E. Bohte, P. Garteiser, A. De Niet, P.F. Groot, R. Sinkus, and J. Stoker MR elastography of the liver: defining thresholds for detecting viscoelastic changes Radiology 269 2013 768 776
116. L. Huwart, C. Sempoux, N. Salameh, J. Jamart, L. Annet, and R. Sinkus Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index Radiology 245 2007 458 466
117. L. Huwart, C. Sempoux, E. Vicaut, N. Salameh, L. Annet, and E. Danse Magnetic resonance elastography for the noninvasive staging of liver fibrosis Gastroenterology 135 2008 32 40
118. M. Yin, J.A. Talwalkar, K.J. Glaser, A. Manduca, R.C. Grimm, and P.J. Rossman Assessment of hepatic fibrosis with magnetic resonance elastography Clin Gastroenterol Hepatol 5 2007 1207 1213
119. P. Asbach, D. Klatt, B. Schlosser, M. Biermer, M. Muche, and A. Rieger Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography Radiology 257 2010 80 86
120. N. Salameh, F. Peeters, R. Sinkus, J. Abarca-Quinones, L. Annet, and L.C. Ter Beek Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat J Magn Reson Imaging 26 2007 956 962
121. B. Coco, F. Oliveri, A.M. Maina, P. Ciccorossi, R. Sacco, and P. Colombatto Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 2007 360 369
122. M. Ronot, S. Lambert, L. Elkrief, S. Doblas, P.E. Rautou, and L. Castera Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis Eur Radiol 24 2014 1394 1402
123. M. Ronot, S. Lambert, M. Wagner, P. Garteiser, S. Doblas, and M. Albuquerque Viscoelastic parameters for quantifying liver fibrosis: three-dimensional multifrequency MR elastography study on thin liver rat slices PLOS One 9 2014 e94679
124. Garteiser P, D'Assignies G, Leitao H, Mouri F, Vilgrain V, Sinkus R, et al. Abstract 373: The influence of inflammation and fibrosis on multifrequency and monofrequency MR elastography parameters: a study in 47 patients with chronic viral hepatitis. Proceedings of the 2014 annual meeting of the International Society of Magnetic Resonance in Medicine.
125. N. Salameh, B. Larrat, J. Abarca-Quinones, S. Pallu, M. Dorvillius, and I. Leclercq Early detection of steatohepatitis in fatty rat liver by using MR elastography Radiology 253 2009 90 97
126. J. Chen, J.A. Talwalkar, M. Yin, K.J. Glaser, S.O. Sanderson, and R.L. Ehman Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography Radiology 259 2011 749 756
127. S.K. Venkatesh, M. Yin, J.F. Glockner, N. Takahashi, P.A. Araoz, and J.A. Talwalkar MR elastography of liver tumors: preliminary results Am J Roentgenol 190 2008 1534 1540
128. P. Garteiser, S. Doblas, J.L. Daire, M. Wagner, H. Leitao, and V. Vilgrain MR elastography of liver tumours: value of viscoelastic properties for tumour characterisation Eur Radiol 22 2012 2169 2177
129. L. Juge, B.T. Doan, J. Seguin, M. Albuquerque, B. Larrat, and N. Mignet Colon tumor growth and antivascular treatment in mice: complementary assessment with MR elastography and diffusion-weighted MR imaging Radiology 264 2012 436 444
130. K.M. Pepin, J. Chen, K.J. Glaser, Y.K. Mariappan, B. Reuland, and S. Ziesmer MR elastography derived shear stiffness-a new imaging biomarker for the assessment of early tumor response to chemotherapy Magn Reson Med 71 2014 1834 1840
131. J. Li, Y. Jamin, J.K. Boult, C. Cummings, J.C. Waterton, and J. Ulloa Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography Br J Cancer 110 2014 1727 1732